NorthView Acquisition Corporation (NVAC)
| Market Cap | 68.23M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 3.90M |
| Shares Out | 6.03M |
| EPS (ttm) | 0.16 |
| PE Ratio | 70.75 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 21 |
| Open | 11.32 |
| Previous Close | 11.92 |
| Day's Range | 11.32 - 11.32 |
| 52-Week Range | 10.34 - 12.42 |
| Beta | 0.02 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About NVAC
NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation operates as a subsidiary of NorthView Sponsor I, LLC. [Read more]
Financial Performance
Financial StatementsNews
NorthView Acquisition Corp Announces Filing a Registration Statement on Form S-4 in Connection with a Proposed Business Combination with Profusa, Inc.
Reflects continuing advancement in the business combination process; transaction expected to be completed during the second quarter of 2023 Reflects continuing advancement in the business combination ...
Profusa, Inc., a Digital Health Company, Pioneering the Next Generation of Personalized Medicine, to Become a Publicly Traded Company Via Merger with NorthView Acquisition Corp
New York, New York, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa”), a digital health company that is pioneering the next generation of personalized medicine and NorthView Acquisition Corp...